RUA.L Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 mai 2024 @ 13:21):

RUA Life Sciences plc, together with its subsidiaries, provides polymers, services, and products to the medical device industry in Europe, the United States, and internationally...

Stats
Dagens volum	99 476.00
Gjennomsnittsvolum	673 797
Markedsverdi	6.95M
EPS	£0 ( 2023-12-19 )
Neste inntjeningsdato	( £0 ) 2024-07-23
Last Dividend	£0 ( N/A )
Next Dividend	£0 ( N/A )
P/E	-1.450
ATR14	£0.149 (1.28%)

Volum Korrelasjon

Lang: -0.15 (neutral)

Kort: -0.53 (weak negative)

Signal:(54.777) Neutral

Rua Life Sciences PLC Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Rua Life Sciences PLC Korrelasjon - Valuta/Råvare

0.38
( neutral )

0.49
( neutral )

0.00
( neutral )

0.51
( weak )

-0.20
( neutral )

-0.10
( neutral )

Rua Life Sciences PLC Økonomi

Annual	2022
Omsetning:	£2.18M
Bruttogevinst:	£1.43M (65.76 %)
EPS:	£-0.0903

FY	2022
Omsetning:	£2.18M
Bruttogevinst:	£1.43M (65.76 %)
EPS:	£-0.0903

FY	2022
Omsetning:	£1.63M
Bruttogevinst:	£1.36M (83.57 %)
EPS:	£-0.0932

FY	2021
Omsetning:	£1.53M
Bruttogevinst:	£1.25M (81.94 %)
EPS:	£-0.0820

Financial Reports:

No articles found.

Rua Life Sciences PLC

RUA Life Sciences plc, together with its subsidiaries, provides polymers, services, and products to the medical device industry in Europe, the United States, and internationally. The company operates as a contract developer and manufacturer of medical devices; and licensor of Elast-Eon and ECSil implantable co-polymers that are used in cardiology and urological applications, including pacing leads, cardiac cannulae, and stent devices, as well as reaction injection molding technology for use in high-precision medical device components. It also develops bore polymer sealed grafts and soft tissue patches; and tri leaflet polymeric heart valves. The company was formerly known as AorTech International plc and changed its name to RUA Life Sciences plc in June 2020. RUA Life Sciences plc was incorporated in 1996 and is headquartered in Irvine, the United Kingdom.